Sonnet BioTherapeutics Merges with Hyperliquid to Form Crypto Treasury
- Sonnet BioTherapeutics shareholders have approved a merger with Hyperliquid Strategies Inc and Rorschach I LLC.
- The newly formed entity, Hyperliquid Strategies Inc (HSI), will hold $888 million in assets.
- HSI will become one of the largest holders of the HYPE token, valued at $583 million.
- The company plans to list on Nasdaq under the ticker HSI.
- A $1.0 billion common stock offering has been filed to expand crypto holdings or support initiatives.
Sonnet BioTherapeutics has merged with Hyperliquid Strategies Inc to create a publicly traded crypto treasury vehicle, holding significant assets including $583 million in HYPE tokens. The new entity, trading as HSI on Nasdaq, positions itself as a major player in the digital asset space.
Source (3.2)https://cryptobriefing.com/hyperliquid-crypto-treasury-strategy/?rand=59535